Skip to content
lifestyle.projectdiaspora.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Skye Bioscience, Inc.
Skye Bioscience and Redx Pharma Announce Transaction Agreement and $125 Million in Financings
August 14, 2026
Skye Announces Cohort Review Committee Approved Opening of Cohort 2 Based on Favorable Safety Data from First Four Participants Treated in Cohort 1
May 22, 2026
UPDATE – Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update
May 20, 2026
Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update
May 20, 2026
Skye Bioscience Presenting at GLP-1-Based Therapeutics Summit
May 3, 2026
Skye Bioscience Treats First Patient in Nimacimab Higher-Dose Expansion Study Evaluating Exposure-Response to Inform Phase 2b Dose Selection for GLP-1 Combination Development
May 2, 2026
Skye Bioscience to Announce 2025 Financial Results and Business Update on March 10, 2026
April 28, 2026
Skye Bioscience Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
March 11, 2026